Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs SSR Mining Inc. Common Stock (SSRM) Price & Performance

Edgewise Therapeutics Inc. Common StockTrade
SSR Mining Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Edgewise Therapeutics Inc. Common Stock vs SSR Mining Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $38.27 (market cap $4.02B), while SSR Mining Inc. Common Stock trades at $30.87 (market cap $6.26B). The key difference: SSR Mining Inc. Common Stock is the larger of the two by market cap, and SSR Mining Inc. Common Stock pays a 0.1% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and SSR Mining Inc. Common Stock for 1 Days on average.

EWTXSSRM
Market Cap
$4.02B$6.26B
Volume
1,446,1284,191,911
Sector
HealthBasic Materials
52-Week High
$48.35$39.21
52-Week Low
$14.89$19.48
Typical Hold Time
0 Days1 Days
Enterprise Value
$3.56B$4.43B
Dividend Yield
—0.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

SSR Mining Inc. Common Stock

SSR Mining (SSRM) trades at $33.09, down 6.63% amid recent volatility, yet maintains strong fundamentals with a P/E of 12.44 and net income margin of 12.3%. The company recently announced the $464 million acquisition of Roxmore Resources, which could add 170,000 ounces of annual gold production. Technical indicators show a bullish trend with support at $34-$35, while earnings have beaten expectations in two of the last three quarters.

The outlook remains positive with a consensus price target of $42.67 (29% upside), driven by strategic acquisitions and Americas-focused growth. Risks include execution of the Roxmore integration and gold price sensitivity. Analysts are bullish (73% buy ratings), citing the company's debt-free balance sheet and $1.8 billion cash position.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWTX
100% Buy0% Sell
Avg holding period · 0 Days
SSRM
100% Buy0% Sell
Avg holding period · 1 Days

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →

About SSR Mining Inc. Common Stock

SSR Mining operates precious-metals mines in the United States, Canada, and Argentina. It produces gold doré and concentrates containing copper, silver, lead, and zinc.

Read more on SSRM →